Catheter Precision, Inc. Cost of Revenue
Catheter Precision, Inc. (VTAK) reported Cost of Revenue of $10.00 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2024-11-14
- Catheter Precision, Inc. cost of revenue for the quarter ending 2024-09-30 was $10.00K, a 66.67% increase year-over-year.
- Catheter Precision, Inc. cost of revenue for the quarter ending 2024-06-30 was $16.00K, a 128.57% increase year-over-year.
- Catheter Precision, Inc. cost of revenue for the quarter ending 2024-03-31 was $5.00K, a 50.00% decline year-over-year.
- Catheter Precision, Inc. cost of revenue for the quarter ending 2023-12-31 was $7.00K.
- Catheter Precision, Inc. cost of revenue for fiscal 2023 was $30.00K, a 81.37% decline from fiscal 2022.
- Catheter Precision, Inc. cost of revenue for fiscal 2022 was $161.00K.
- Catheter Precision, Inc. cost of revenue for fiscal 2020 was $5.48M, a 38.06% decline from fiscal 2019.
- Catheter Precision, Inc. cost of revenue for fiscal 2019 was $8.85M, a 110.41% increase from fiscal 2018.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2024-09-30 | $10.00K 10-Q · filed 2024-11-14 | $26.00K derived: sum of 2 quarters · filed 2024-11-14 | $31.00K 10-Q · filed 2024-11-14 | $38.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-06-30 | $16.00K 10-Q · filed 2024-08-14 | $21.00K 10-Q · filed 2024-08-14 | $28.00K derived: sum of 3 quarters · filed 2024-08-14 | $34.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-03-31 | $5.00K 10-Q · filed 2024-05-06 | $12.00K derived: sum of 2 quarters · filed 2024-05-06 | $18.00K derived: sum of 3 quarters · filed 2024-11-14 | $25.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $13.00K derived: sum of 2 quarters · filed 2024-11-14 | $20.00K derived: sum of 3 quarters · filed 2024-11-14 | $30.00K 10-K · filed 2024-04-01 |
| 2023-09-30 | $6.00K 10-Q · filed 2024-11-14 | $13.00K derived: sum of 2 quarters · filed 2024-11-14 | $23.00K 10-Q · filed 2024-11-14 | $23.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $7.00K 10-Q · filed 2024-08-14 | $17.00K 10-Q · filed 2024-08-14 | $17.00K derived: sum of 3 quarters · filed 2024-08-14 | $17.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $10.00K 10-Q · filed 2024-05-06 | $10.00K derived: sum of 2 quarters · filed 2024-05-06 | $10.00K derived: sum of 3 quarters · filed 2024-05-06 | $76.00K derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | $66.00K derived: sum of 3 quarters · filed 2024-04-01 | $161.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $0.00 10-Q · filed 2023-12-21 | $66.00K derived: sum of 2 quarters · filed 2023-12-21 | $161.00K 10-Q · filed 2023-12-21 | |
| 2022-06-30 | $66.00K 10-Q · filed 2023-12-15 | $161.00K 10-Q · filed 2023-12-15 | ||
| 2022-03-31 | $95.00K 10-Q · filed 2023-06-02 | |||
| 2021-06-30 | $1.49M 10-Q · filed 2021-08-11 | $2.86M 10-Q · filed 2021-08-11 | $4.17M derived: sum of 3 quarters · filed 2021-08-11 | $5.59M derived: sum of 4 quarters · filed 2021-08-11 |
| 2021-03-31 | $1.37M 10-Q · filed 2021-05-12 | $2.69M derived: sum of 2 quarters · filed 2021-05-12 | $4.10M derived: sum of 3 quarters · filed 2021-05-12 | $5.27M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $2.73M derived: sum of 2 quarters · filed 2021-03-17 | $3.90M derived: sum of 3 quarters · filed 2021-08-11 | $5.48M 10-K · filed 2021-03-17 |
| 2020-09-30 | $1.42M 10-Q · filed 2020-11-16 | $2.58M derived: sum of 2 quarters · filed 2021-08-11 | $4.17M 10-Q · filed 2020-11-16 | $5.92M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-06-30 | $1.17M 10-Q · filed 2021-08-11 | $2.75M 10-Q · filed 2021-08-11 | $4.50M derived: sum of 3 quarters · filed 2021-08-11 | $6.93M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $1.58M 10-Q · filed 2021-05-12 | $3.33M derived: sum of 2 quarters · filed 2021-05-12 | $5.76M derived: sum of 3 quarters · filed 2021-05-12 | $8.49M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $4.17M derived: sum of 2 quarters · filed 2021-03-17 | $6.91M derived: sum of 3 quarters · filed 2021-03-17 | $8.85M 10-K · filed 2021-03-17 |
| 2019-09-30 | $2.42M 10-Q · filed 2020-11-16 | $5.16M derived: sum of 2 quarters · filed 2020-11-16 | $7.10M 10-Q · filed 2020-11-16 | $8.30M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $2.73M 10-Q · filed 2020-08-11 | $4.67M 10-Q · filed 2020-08-11 | $5.88M derived: sum of 3 quarters · filed 2020-08-11 | $7.16M derived: sum of 4 quarters · filed 2020-08-11 |
| 2019-03-31 | $1.94M 10-Q · filed 2020-05-14 | $3.14M derived: sum of 2 quarters · filed 2020-05-14 | $4.42M derived: sum of 3 quarters · filed 2020-05-14 | $5.41M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $2.48M derived: sum of 2 quarters · filed 2020-03-11 | $3.47M derived: sum of 3 quarters · filed 2020-03-11 | $4.21M 10-K · filed 2020-03-11 |
| 2018-09-30 | $1.28M 10-Q · filed 2019-11-29 | $2.27M derived: sum of 2 quarters · filed 2019-11-29 | $3.01M 10-Q · filed 2019-11-29 | $4.66M derived: sum of 4 quarters · filed 2019-11-29 |
| 2018-06-30 | $990.00K 10-Q · filed 2019-11-29 | $1.73M 10-Q · filed 2019-11-29 | $3.38M derived: sum of 3 quarters · filed 2019-11-29 | $4.08M derived: sum of 4 quarters · filed 2019-11-29 |
| 2018-03-31 | $736.00K 10-Q · filed 2019-05-14 | $2.39M derived: sum of 2 quarters · filed 2019-05-14 | $3.09M derived: sum of 3 quarters · filed 2019-05-14 | |
| 2017-12-31 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $2.35M derived: sum of 2 quarters · filed 2019-03-15 | $4.17M 10-K · filed 2019-03-15 | |
| 2017-09-30 | $693.00K 10-Q · filed 2018-11-14 | $2.51M 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |